Vedolizumab: an α4β7 integrin inhibitor for inflammatory bowel diseases.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2014
published in
- The Annals of pharmacotherapy Journal